| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/02/2004 | WO2004104045A1 Therapeutical use of anti-cd70 antibody for treating or preventing aids |
| 12/02/2004 | WO2004104043A1 A synthetic bioelastomer |
| 12/02/2004 | WO2004104042A1 A bioelastomer |
| 12/02/2004 | WO2004104041A1 Materials and methods relating to g-protein coupled receptor oligomers |
| 12/02/2004 | WO2004104040A1 Tnf-like secreted protein |
| 12/02/2004 | WO2004104039A2 Tumor antigens for prevention and/or treatment of cancer |
| 12/02/2004 | WO2004104038A1 Control of the intracellular localization of ip3 receptor |
| 12/02/2004 | WO2004104036A1 Process for producing soyeban whey protein and digested soybean whey protein |
| 12/02/2004 | WO2004104035A1 Regulation of growth in plants |
| 12/02/2004 | WO2004104033A2 Viruses dependent on inducing agents for viral entry into a host cell |
| 12/02/2004 | WO2004104031A2 Modified antiviral peptides with increased activity and cell membrane affinity |
| 12/02/2004 | WO2004104029A1 Spheron components useful in determining compounds capable of treating symptoms of alzheimer’s disease |
| 12/02/2004 | WO2004104028A1 Anti-inflammatory agents |
| 12/02/2004 | WO2004104027A1 Composition containing angiotensin converting enzyme inhibitory peptide |
| 12/02/2004 | WO2004104023A2 Metal chelate complexes immobilized on solid supports for peptide preparation |
| 12/02/2004 | WO2004104020A2 Repeat sequence protein polymer active agent conjugates, methods and uses |
| 12/02/2004 | WO2004103410A1 Methods compositions and articles of manufacture for modulating bone growth |
| 12/02/2004 | WO2004103400A2 Multivalent meningococcal derivatized polysaccharide-protein conjugates and corresponding vaccines |
| 12/02/2004 | WO2004103393A1 CONTROL OF FUNCTION OF INTRACELLULAR Ca ION |
| 12/02/2004 | WO2004103390A2 Stable analogs of peptide and polypeptide therapeutics |
| 12/02/2004 | WO2004103389A2 Means for preventing and treating cellular death and their biological applications |
| 12/02/2004 | WO2004103295A2 Interleukin-9 antagonist muteins and their pharmacological methods of use |
| 12/02/2004 | WO2004103292A2 Process for manufacture of nematode-extracted anticoagulant protein (nap) |
| 12/02/2004 | WO2004103275A2 Compositions and methods for the preparation of human growth hormone glycosylation mutants |
| 12/02/2004 | WO2004103273A2 Inverse agonist and agonist peptides that stimulate/inhibit hair growth |
| 12/02/2004 | WO2004103269A2 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus borrelia |
| 12/02/2004 | WO2004103149A2 Genes encoding single chain human leukocyte antigen e (hla-e) proteins to prevent natural killer cell-mediated cytotoxicity |
| 12/02/2004 | WO2004103067A2 A transgenic animal model for cancer and stem cells |
| 12/02/2004 | WO2004096827A3 Plant retroelements and methods related thereto |
| 12/02/2004 | WO2004092201A3 Enhanced hiv-1 vaccines and methods for their use |
| 12/02/2004 | WO2004081174A3 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker |
| 12/02/2004 | WO2004069870A3 Differentially expressed nucleic acids in the blood-brain barrier under inflammatory conditions |
| 12/02/2004 | WO2004067563A8 Peptide inhibitors of toxins derived from ll-37 |
| 12/02/2004 | WO2004063362A3 Cell cycle progression proteins |
| 12/02/2004 | WO2004060916A3 Peptide compound containing boron |
| 12/02/2004 | WO2004058819A3 Crystalline liver x receptor beta protein |
| 12/02/2004 | WO2004058811A3 Crystal structures of yhhf polypeptides |
| 12/02/2004 | WO2004050834A3 GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER |
| 12/02/2004 | WO2004047758A3 Methods of therapy and diagnosis using targeting of cells that express p2y10 |
| 12/02/2004 | WO2004046345A3 Use of hmgb fragments as anti-inflammatory agents |
| 12/02/2004 | WO2004043347A3 Calcitonin drug-oligomer conjugates, and uses thereof |
| 12/02/2004 | WO2004036011A3 Biomolecular-based actuator |
| 12/02/2004 | WO2004035750A3 Methods for accumulating translocated proteins |
| 12/02/2004 | WO2004029276A3 Nucleic acids encoding a mammalian raptor polypeptide and uses therefor |
| 12/02/2004 | WO2004027020A3 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis |
| 12/02/2004 | WO2004018631A3 G-protein coupled receptors |
| 12/02/2004 | WO2004013308A3 Maxs as modifiers of the axin pathway and methods of use |
| 12/02/2004 | WO2004013295A3 Plant rna binding protein, encoding nucleic acids, and methods of use |
| 12/02/2004 | WO2004009797A3 Protein modification and maintenance molecules |
| 12/02/2004 | WO2004009788A3 Fluorescent proteins, nucleic acids encoding them and methods for making and using them |
| 12/02/2004 | WO2004007693A3 Human immunosuppressive protein |
| 12/02/2004 | WO2004005221A3 Benzoate- and anthranilate-inducible promoters |
| 12/02/2004 | WO2003095667A3 Autoimmune conditions and nadph oxidase defects |
| 12/02/2004 | WO2003085377A3 Novel pancortin-pablo protein interactions and methods of use thereof |
| 12/02/2004 | WO2003083079A8 Bone generation by gene therapy |
| 12/02/2004 | WO2003078465A8 The use of an epitope of vascular endothelial growth factor receptor kdr/flk-1 |
| 12/02/2004 | WO2003073066A3 Reagents and methods for assaying bacillus anthracis lethal factor protease |
| 12/02/2004 | WO2003072709A3 Variant tat proteins and methods for use thereof |
| 12/02/2004 | WO2003056020A8 Expression vectors and promoters for heterologous gene expression |
| 12/02/2004 | WO2003050235A3 Polynucleotide encoding a novel human potassium channel alpha-subunit, k+alpham2 |
| 12/02/2004 | WO2003048326A3 Methods and materials relating to novel polypeptides and polynucleotides |
| 12/02/2004 | WO2003039348A3 Intracellular signaling molecules |
| 12/02/2004 | WO2003028632A3 Development of a preventive vaccine for filovirus infection in primates |
| 12/02/2004 | WO2003027240A3 Rhesus monkey, dog and ferret melanin-concentrating hormone type 1 receptor |
| 12/02/2004 | WO2003027230A3 Cell adhesion and extracellular matrix proteins |
| 12/02/2004 | WO2003014298A3 Full-length prostate selective polynucleotides and polypeptides |
| 12/02/2004 | WO2002051981A3 Defects in periaxin associated with myelinopathies |
| 12/02/2004 | US20040244079 Protein that has a function of maintaining a mutation whereby lateral root formation is blocked and a gene encoding the protein |
| 12/02/2004 | US20040244078 Isolated nucleic acid of given sequence, encoding a polypeptide; use in controlling growth and seed development; gene constructs; genetic engineering |
| 12/02/2004 | US20040244070 Expression of polypeptides in rod outer segment membranes |
| 12/02/2004 | US20040244069 Somatic and/or germ cells comprising a nucleic acid with promoter capable of directing protein expression; use in treating, diagnosing and preventing osteoporosis |
| 12/02/2004 | US20040244067 Transgenic mammal which has increased lung mucus retention and whose genome comprises a promoter linked to a heterologous DNA encoding an epithelial sodium channel subunit; useful in treatment of bronchitis and asthma. |
| 12/02/2004 | US20040244066 Multidrug resistance proteins in Drosophila and Anopheles |
| 12/02/2004 | US20040244062 Use of protein inhibitors as antithrombotic agents |
| 12/02/2004 | US20040243319 Three-dimensional model; drug design |
| 12/02/2004 | US20040243316 Crystallographic structure of the androgen receptor ligand binding domain |
| 12/02/2004 | US20040242860 Compositions and methods for the diagnosis and treatment of tumor |
| 12/02/2004 | US20040242859 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments |
| 12/02/2004 | US20040242853 Glp-1 exendin-4 peptide analogs and uses thereof |
| 12/02/2004 | US20040242850 Monoclonal antibody for use as diagnostic agent in monitoring nervous system development |
| 12/02/2004 | US20040242846 Preparing and isolating multimeric blood protein for use as component of blood substitute; artificial erythrocytes |
| 12/02/2004 | US20040242845 Methods and compositions comprising supramolecular antigenic constructs and antibodies elicited against them |
| 12/02/2004 | US20040242844 Nucleotide sequences coding streptococcus capsular polysaccharide antigens for use in diagnosis and prevention of infections in mammals; veterinary medicine |
| 12/02/2004 | US20040242843 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/02/2004 | US20040242842 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use |
| 12/02/2004 | US20040242515 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy home-ostasis |
| 12/02/2004 | US20040242513 Tub antisense constructs |
| 12/02/2004 | US20040242512 Novel vectors for animal cells and utilization thereof |
| 12/02/2004 | US20040242488 Peptides having same amino acid sequence and same anti-microbial activity as those of Phylloseptins which are isolated from the skin of Phyllomedusa hypochondrialis; the 19-residue anti-microbial peptides are cationic and based on their primary structure, all peptides can fitted to an amphiphilic a-helix |
| 12/02/2004 | US20040242487 Identifying a subject in need of inhibiting appetite or weight gain and administering an effective amount of an antagonist of melanocyte concentrating hormone (MCH) to subject, wherein antagonist binds an MCH receptor |
| 12/02/2004 | US20040242486 for promoting the survival, growth, proliferation, or maintenance of neurons in an injured but not severed spinal cord; promoting axonal regeneration, inhibiting the effects of scar tissue formation; antiapoptotic agents |
| 12/02/2004 | US20040242484 Specific polypeptides, useful as nematocides |
| 12/02/2004 | US20040242483 Molecules, compositions, methods and kits for applications associated with flaviviruses |
| 12/02/2004 | US20040242479 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells |
| 12/02/2004 | US20040242476 Peptide and analogs thereof having an amino acid sequence corresponding to the second extracellular domain of a mammalian occludin; may be administered orally or parenterally |
| 12/02/2004 | US20040242475 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 12/02/2004 | US20040242474 High density lipoprotein-reactive peptides |
| 12/02/2004 | US20040242473 Epidermal growth factor peptide for diagnosis and treatment cancer; antiproliferative agents |
| 12/02/2004 | US20040242472 Use of artemin, a member of the gdnf ligand family |
| 12/02/2004 | US20040242471 Dormancy induced mycobacterium proteins |